Medication info
Empagliflozin 25 mg (Empagliflozin 2L-Proline)

Empagliflozin 25 mg (Empagliflozin 2L-Proline)

Prescription medicationTabletOral
Ingredient · strength
Empagliflozin 2L-Proline›37.77mg / 1 tablet
Manufacturer / importer
Kyungbo Pharmaceutical Co., Ltd.
Appearance
Light yellow oblong film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202502903 · Approved 2025.11.10

Summary

Main use
Improvement of glycemic control in adults with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The recommended dose of this drug is 10 mg once daily for monotherapy and as add-on combination therapy with other blood glucose-lowering agents, such as insulin. If 10 mg of this drug is well tolerated and additional glycemic control is needed, the dose may be increased to 25 mg once daily. When this drug is administered together with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 3. Adverse Reactions). This drug may be administered with or without food. Swallow the tablet whole. If you miss a dose of this drug, take it as soon as you remember. Do not take a double dose in one day. Special populations •Patients with renal impairment This drug is not recommended for patients with an estimated glomerular filtration rate (eGFR) of less than 45 ml/min/1.73m2 when used to improve glycemic control. No dose adjustment is necessary for patients with an estimated glomerular filtration rate of 45 ml/min/1.73m2 or higher. Do not use this drug in patients with end-stage renal disease (ESRD) or those receiving dialysis, as efficacy is not expected in these patients. •Patients with hepatic impairment No dose adjustment is necessary for patients with mild or moderate hepatic impairment. Use of this drug is not recommended in patients with severe hepatic impairment, as it has not been studied in these patients. •Elderly patients No dose adjustment is necessary based on age. In patients aged 75 years and older, consider renal function and the risk of volume depletion (see Precautions for Use, 4. General Precautions).

Ingredients

Manufacturer
Kyungbo Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in adults with type 2 diabetes mellitus

  • Adult patients with Type 2 diabetes
  • blood sugar control disorders
  • cardiovascular diseases
View approved original text

This medication is an adjunct to diet and exercise to improve blood sugar control in adult patients with Type 2 diabetes. It can be used alone or in combination with other medications. It is particularly effective for patients whose blood sugar is not sufficiently controlled, and caution is needed for patients with cardiovascular disease regarding the occurrence of cardiovascular events. While taking this medication, please follow the directions of healthcare professionals and verify the precautions for use. This medication helps manage diabetes by improving blood sugar control.

How to take

Adult dose

The recommended dose of this drug is 10 mg once daily for monotherapy and as add-on combination therapy with other blood glucose-lowering agents, such as insulin. If 10 mg of this drug is well tolerated and additional glycemic control is needed, the dose may be increased to 25 mg once daily. When this drug is administered together with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 3. Adverse Reactions). This drug may be administered with or without food. Swallow the tablet whole. If you miss a dose of this drug, take it as soon as you remember. Do not take a double dose in one day. Special populations •Patients with renal impairment This drug is not recommended for patients with an estimated glomerular filtration rate (eGFR) of less than 45 ml/min/1.73m2 when used to improve glycemic control. No dose adjustment is necessary for patients with an estimated glomerular filtration rate of 45 ml/min/1.73m2 or higher. Do not use this drug in patients with end-stage renal disease (ESRD) or those receiving dialysis, as efficacy is not expected in these patients. •Patients with hepatic impairment No dose adjustment is necessary for patients with mild or moderate hepatic impairment. Use of this drug is not recommended in patients with severe hepatic impairment, as it has not been studied in these patients. •Elderly patients No dose adjustment is necessary based on age. In patients aged 75 years and older, consider renal function and the risk of volume depletion (see Precautions for Use, 4. General Precautions).

Precautions

This medication should not be used in patients who are allergic to the active or inactive ingredients. It should also not be administered to patients with Type 1 diabetes or diabetic ketoacidosis. Patients with impaired kidney function may experience reduced effectiveness of this medication, and kidney function should be monitored regularly. The use of this medication is not recommended in cases of severely impaired kidney function. When used alongside insulin or sulfonylureas, there is a risk of hypoglycemia, and dosage adjustments of those medications may be necessary. During treatment, attention should be paid to symptoms of hypoglycemia, especially when taken with insulin or sulfonylureas. Genital infections or urinary tract infections may occur; if infection symptoms arise, consult a healthcare provider promptly. Reduced fluid volume may lead to low blood pressure, so patients at risk of dehydration or low blood pressure should be cautious. Serious metabolic acidosis called ketoacidosis may occur, so if symptoms such as vomiting, abdominal pain, or difficulty breathing arise, seek medical attention immediately. Elderly patients or those at risk of fluid loss should closely monitor their fluid status, and may pause the medication if needed. It is advisable to avoid use during pregnancy, and the medication should be halted if pregnancy is confirmed. During breastfeeding, it is recommended to avoid this medication and stop breastfeeding. Safety and effectiveness in children have not been established, and use in this population should be avoided. No specific toxic symptoms have been reported in cases of overdose, but appropriate treatment based on clinical condition may be necessary. During treatment, be cautious of hypoglycemia risk while driving or operating machinery. This medication may interact with other drugs, so inform your healthcare provider of any other medications being taken. When storing this medication, keep it out of reach of children and do not transfer to other containers.

Side effects

  • Hypoglycemia
  • ketoacidosis
  • constipation
  • pruritus
  • rash
  • urticaria
  • angioedema
  • reduced fluid volume
  • increased urination
  • urination difficulties
Show 199 more
  • interstitial nephritis
  • thirst
  • increased serum lipids
  • increased blood creatinine
  • reduced glomerular filtration rate
  • vulvar myelination
  • vulvitis
  • balanitis
  • urinary tract infection
  • perineal necrosis
  • nausea
  • gastric ulcer
  • colitis
  • vomiting
  • ischemic colitis
  • gastrointestinal bleeding
  • soft tissue infection
  • appendiceal abscess
  • appendicitis
  • meningitis
  • chronic otitis media
  • peritonsillar abscess
  • pneumonia
  • pulmonary tuberculosis
  • acute pyelonephritis
  • sepsis
  • subcutaneous abscess
  • tubal-ovarian abscess
  • vestibular neuritis
  • headache
  • cerebral infarction
  • intracranial aneurysm
  • fever
  • vascular stent stenosis
  • vascular stent thrombosis
  • ureteral stones
  • acute kidney injury
  • cervicitis
  • hyperglycemia
  • hyponatremia
  • diabetic foot
  • low back pain
  • glaucoma
  • pathological myopia
  • retinal detachment
  • retinal vein occlusion
  • tears in the retina
  • limb injury
  • road traffic accident
  • splenic injury
  • sternum fracture
  • angina
  • Prinzmetal angina
  • coronary artery disease
  • deep vein thrombosis
  • benign neoplasm of the Bauer ampulla
  • benign ovarian tumor
  • bladder cancer
  • gastric cancer
  • pancreatic adenocarcinoma
  • rectal cancer
  • thyroid cancer
  • uterine leiomyoma
  • acute cholecystitis
  • autoimmune hepatitis
  • cholelithiasis
  • hyperacusis
  • positional vertigo
  • dizziness
  • anemia
  • lymphadenopathy
  • hypothyroidism
  • thyroid nodule
  • epigastric pain
  • dental caries
  • erosive gastritis
  • abdominal discomfort
  • gastroesophageal reflux disease
  • abdominal distention
  • rectal bleeding
  • chronic gastritis
  • enteritis
  • bloating
  • gastric polyp
  • gingival swelling
  • passage of blood in stool
  • hemorrhoids
  • pancreatic cyst
  • rectal pain
  • toothache
  • dyspepsia
  • upper respiratory infection
  • bronchitis
  • chronic sinusitis
  • gastroenteritis
  • Helicobacter infection
  • periodontitis
  • chronic tonsillitis
  • conjunctivitis
  • influenza
  • laryngitis
  • tinea capitis
  • dental abscess
  • nasopharyngitis
  • positional dizziness
  • sensory loss
  • perceptual anomaly
  • amnesia
  • carotid stenosis
  • diabetic neuropathy
  • facial paralysis
  • memory impairment
  • neuralgia
  • Parkinson's disease
  • polyneuropathy
  • drowsiness
  • fatigue
  • peripheral edema
  • facial edema
  • peripheral swelling
  • chills
  • strange sensations
  • edema
  • pain
  • pain at the puncture site
  • weight gain
  • electrocardiogram abnormalities
  • decreased hemoglobin
  • increased hemoglobin
  • positive Helicobacter test
  • positive urine red blood cells
  • hematuria
  • overactive bladder
  • renal mass
  • urinary retention
  • urinary pain
  • abnormal urination
  • benign prostatic hyperplasia
  • erectile dysfunction
  • atrophic vulvitis
  • cervical dysplasia
  • vaginal discharge
  • hypoglycemia
  • decreased appetite
  • obesity
  • hypersomnia
  • hyperlipidemia
  • vitamin D deficiency
  • dermoid cyst
  • seborrheic dermatitis
  • atopic dermatitis
  • nummular eczema
  • heat rash
  • sebaceous gland hyperplasia
  • lumbar spinal stenosis
  • myalgia
  • limb pain
  • musculoskeletal chest pain
  • arthralgia
  • cervical stenosis
  • fibromyalgia
  • flank pain
  • fracture pain
  • muscle weakness
  • osteoarthritis
  • osteoporosis
  • rotator cuff syndrome
  • astigmatism
  • cataracts
  • allergic conjunctivitis
  • blurred vision
  • corneal erosion
  • macular fibrosis
  • ocular discomfort
  • ocular congestion
  • eyelid edema
  • visual impairment
  • vitreous floaters
  • vitreous hemorrhage
  • nasal bleeding
  • asthma
  • age-related dyspnea
  • wet cough
  • allergic rhinitis
  • residual phlegm
  • skin laceration
  • contusion
  • rib fracture
  • concussion
  • corneal abrasion
  • falls
  • hand fracture
  • iliotibial band syndrome
  • open eye injury
  • pelvic fracture
  • anxiety
  • depression
  • sleep disorders
  • insomnia

Not everyone experiences these, and they can vary from person to person.

Storage

The medication should be stored in a tightly sealed container to protect it from air and moisture, at a safe temperature between 1 and 30 degrees Celsius. Proper storage can help maintain the medication's efficacy for a longer period.

Appearance and packaging

Appearance

Light yellow oblong film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.